IDH1 Inhibitor Shows Promising Early Results

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-nb2014-178
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Early Start to Suicide Prevention: Children’s Programme Shows Promising Results

Suicidologi
2015English

Combination Treatment of an IDH1 Inhibitor With Chemotherapy in IDH1 Mutant Acute Myeloid Leukemia

Annals of Hematology
MedicineHematology
2020English

A Brain Penetrant Mutant IDH1 Inhibitor Provides in Vivo Survival Benefit

Scientific Reports
Multidisciplinary
2017English

Mutant IDH2 Inhibitor Looks Promising in AML

Cancer Discovery
Oncology
2014English

A Selective FLT3 Inhibitor Shows Clinical Efficacy in AML

Cancer Discovery
Oncology
2013English

The Biodistribution of Self-Assembling Protein Nanoparticles Shows They Are Promising Vaccine Platforms

Journal of Nanobiotechnology
Applied MicrobiologyMolecular MedicineNanosciencePharmaceutical ScienceMedicineBiotechnologyBioengineeringBiomedical EngineeringNanotechnology
2013English

Structure Based Discovery of Clomifene as a Potent Inhibitor of Cancer-Associated Mutant IDH1

Oncotarget
Oncology
2017English

Cambinol, a Novel Inhibitor of Neutral Sphingomyelinase 2 Shows Neuroprotective Properties

PLoS ONE
Multidisciplinary
2015English

IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas

American Journal of Pathology
Forensic MedicinePathology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy